The specificity of retinal cells transduced by AAV serotype 1, 2 or 5 vectors was determined in vivo versus in vitro in the normal P7 mouse in order to develop a rapid and accurate way to anticipate the behavior of AAV vectors in the retina. In vivo results confirm that AAV1 transduces retinal pigment epithelial cells, while AAV2 and AAV5 transduce both RPE and photoreceptor cells by subretinal injection. AAV2 was the only serotype to efficiently transduce inner retinal cells by intravitreal injection. Parallel analysis employing in vitro retinal organ culture showed qualitatively similar AAV-mediated GFP expression as seen in vivo suggesting that organ culture substitute is a useful method to screen new vector transduction patterns, particular in retinal cells in neonatal mice.
Introduction
Adeno-associated viruses (AAVs), members of the Parvovirus family, have been isolated from many different mammalian species, including humans. Human AAV has been widely exploited as a vector for gene delivery to different tissues and organs, especially to retina because of its advantages over other viral gene therapy vectors, namely: safety, long term expression, ability to transduce terminally differentiated cells and selective (as well as broad) tropism through the use of the numerous AAV serotypes currently available (Bainbridge et al., 2003; Bennett et al., 1999; Dinculescu, Glushakova, Min, & Hauswirth, 2005; Dudus et al., 1999; Flotte & Berns, 2005; Guy, Qi, Muzyczka, & Hauswirth, 1999; Liang, Surace, Dejneka, Maguire, & Bennett, 2003; Rabinowitz et al., 2002; Surace et al., 2003; Yang et al., 2002; Zolotukhin, Potter, Hauswirth, Guy, & Muzyczka, 1996) . Infection by wild type AAVs, naturally defective for replication, results in latent infection, and all human serotypes are classified as nonpathogenic (Laughlin, Jones, & Carter, 1982) . Recombinant AAV is produced by removing all native AAV coding sequences leaving only the short inverted terminal repeats (ITRs) flanking the promoter, cDNA and polyA-addition site of interest. More than 100 variants of AAV have been categorized into serotypes and genomovars (Gao et al., 2004) , resulting in a broad diversity of AAV serotypes that utilize a range of cell surface receptors (Flotte & Berns, 2005) . There are nine serotypes of AAV currently in use as vectors, AAV serotypes 1-9, which differ from each other primarily based on capsid protein sequence. Capsid variations confer distinct tissue and cell affinities, and eventually play a role in defining the rate of expression onset and overall 0042-6989/$ -see front matter Ó 2007 Elsevier Ltd. All rights reserved. doi:10.1016/j.visres. 2007 .08. 009 intensity of transgene expression. AAV serotype 2 (AAV2) was the first used for gene transfer. Currently, almost all non-AAV2 vectors are made by packaging the vector DNA flanked by serotype 2 ITRs into the desired capsid serotype, a process termed ''pseudotyping''. For example, AAV1 vector that is flanked by AAV2 ITRs but packaged into AAV1 capsid proteins, similarly AAV5 vectors are made by packaging AAV2 into the AAV5 capsid.
In adult mice, subretinal injection of AAV2 vector delivering a reporter gene driven by an ubiquitous promoter results in transduction of RPE and photoreceptor cells (PRs). In contrast, intravitreal injection of AAV2 leads to transduction of retinal ganglion cells (RGCs), and various cells of the inner nuclear layer, including Muller cells (Davidson et al., 2000; Liang et al., 2003; Martin, Klein, & Quigley, 2002; Yang et al., 2002) . Stable transgene expression is observed 2-4 weeks after injection in mice (Ali et al., 1996; Bennett, Duan, Engelhardt, & Maguire, 1997; Sarra et al., 2002) . In contrast, subretinal administration of AAV1 demonstrates transgene GFP expression restricted to RPE cells (Auricchio, 2003) . Expression via AAV5 vectors following subretinal injection begins 2-4 weeks post-injection and transduces both RPE and photoreceptor cells (Auricchio et al., 2001 ). The transduction efficiency in PR cells appeared to be higher for AAV5 than for AAV2. Little transgene expression is observed following intravitreal injection of either AAV1 or AAV5 (Auricchio et al., 2001) . Expression patterns of the other serotypes in the retina have been explored as well, but to a lesser degree. AAV6 and AAV4 transduce primarily RPE cells, similar to AAV1 (Weber et al., 2003; Yang et al., 2002) . AAV3 transduces retinal cells poorly (Auricchio et al., 2001; Weber et al., 2003; Yang et al., 2002) . Our unpublished data showed that AAV7, AAV8 and AAV9 transfect RPE and photoreceptor cells when delivered subretinally but do not transfect inner retinal cells following intravitreal injection, properties similar to AAV5.
Although isolation of new AAV serotypes (Gao et al., 2002; Inagaki et al., 2006; Mori, Wang, Takeuchi, & Kanda, 2004) opens the possibility of developing better gene delivery vehicles, most retinal cells that are targets for gene therapy can be transfected by AAV1, 2 or 5 when combined with the appropriate injection site. Based on many studies of the behavior of AAV vector serotypes in the retina, including cell specificity, efficiency, stability and immunogenicity (Auricchio, 2003; Bainbridge et al., 2003; Dinculescu et al., 2005; Guy et al., 1999; Liang et al., 2003; Martin et al., 2002; Rabinowitz et al., 2002; Stieger et al., 2006; Surace et al., 2003; Yang et al., 2002; Zolotukhin et al., 1996) , AAV vectors are clearly a promising tool for retinal gene delivery in a wide variety of disease contexts and have been used to deliver therapeutic genes to correct disorders in animal models of various human retinal diseases (Acland et al., 2005; Alexander et al., 2007; Batten et al., 2005; Davidson et al., 2000; Deng et al., 2005; Haire et al., 2006; Hennig et al., 2004; Leaver et Currently, in order to study the behavior of AAV vectors in the retina, it is necessary to evaluate transduced retinal tissue following in vivo vector administration. Such in vivo procedures, while serving as reliable ways to observe the effects of AAV vectors in adult mice, have several drawbacks principally related to the uncertainty of the site of vector delivery and as to whether vector intended for the subretinal space has partially leaked back into the vitreous cavity. Additionally neonatal injections, necessary for rapid retinal degenerative mice, such as rd1 and rd10 mice, are even more difficult to control and require practiced surgical skills in order to obtain reproducible results. Utilizing the trans-sclera subretinal route for subretinal injection (Pang et al., 2006b ), typically only 20-30% of a neonatal retina can be transduced. There is also high incidence of injection-related retinal damage that could influence evaluation of the transferred therapeutic factor. Therefore, it often becomes difficult to determine whether a poor response to a potential therapeutic factor is due to minimally transduced retinal area, to retinal damage caused by technical problems or that the expression of the transgene itself fails to rescue the disease phenotype. Along with these inherent uncertainties, one must typically wait for several weeks or months to obtain results (Ali et al., 1996; Bennett et al., 1997; Sarra et al., 2002) . In view of limitation of in vivo procedures, we evaluated an in vitro approach that could make analysis of the spectrum of transduction of vectors within the retina easier, quicker, and more cost effective. An in vitro retinal model using short-term retinal organ cultures has recently been described (Hatakeyama & Kageyama, 2002; Pang et al., 2004) and could be utilized for this purpose. For this to be a viable alternative to in vivo assays however, it must first be shown that AAV vectors in neonatal retina behave analogously in organ culture and in vivo. To fully test this concept, we compared side-by-side, the cell transduction properties of AAV1, AAV2 and AAV5 vectors in normal neonatal mouse retinas both in vivo and in vitro.
Materials and methods

Animals
C57BL/6. mice (Jackson Laboratory, Bar Harbor, ME) were used in this study. The mice were housed and bred in the University of Florida's animal facility. All animal experimentation was conducted under local IACUC approved protocols in accordance with the ARVO statement for the Use of Animals in Ophthalmic and Vision Research. At least 6 eyes were used for each group of experiment and about 70 C57BL/6 mice were used in this study.
Recombinant adeno-associated virus preparation
AAV constructs used in this experiment were based on the pTR-UF2 vector (Flannery et al., 1997) . Vector preparation requires three main steps as previously described (Zolotukhin et al., 1996) . Briefly, two different plasmids were co-transfected into HEK 293 cells: one plasmid contained the GFP expression cassette driven by the CBA promoter packaged between the AAV2 internal terminal repeats. The second helper plasmid contained the AAV rep and cap genes and the adenovirus E1, E2, and E3 genes. For production of AAV1 and AAV5, the helper plasmids contained the cap genes of AAV1 and AAV5, respectively. The virus was purified on an iodixinol gradient followed by anion exchange column chromatography. The viral physical titers were assessed by quantitative competitive PCR (Zolotukhin et al., 2002) .
Retinal organ culture and vector administration
Retinal explant cultures were established by following the protocol of Ogilvie, Speck, Lett, and Fleming (1999) with modifications (Pang et al., 2004) . Briefly, eyes of P7 C57BL/6 pups were enucleated and the choroid, sclera, and cornea were removed. The remaining retinas, lens and vitreous were incubated with fresh DMEM for 45 min at 37°C. The RPE was then gently teased away from the retina using an angled forceps. The lens with attached vitreous was removed and the retinal explants were cut at four corners to flatten it. With the photoreceptor side down, the retinas were transferred into individual wells of Millicell-CM culture insert (0.4 mm, by 30 mm, Millipore Bedford, MA) containing 1 ml of fresh DMEM. The medium was removed from the insert and the edges of the retina were flattened via light brushing. Retinal explants were exposed to 10 ll (approx. 5 · 10 12 particles) of either AAV1, 2 or 5. Vector was placed directly on the inner retinal surface, the upper face of the explant, noted as the retinal ganglion cell (RGC) surface for 30 min. Alternatively, the PR side of the explant was exposed to vector by placing 10 ll vector suspensions on the insert membrane next to the explant and then gently sliding explant on top of the vector for 30 min. One milliliter of DMEM was then added to each well. After 24 h, explants were rinsed and incubated in DMEM containing 10% FBS plus Fungizone (1.25 lg/ml) for another 4 days in vitro (DIV). The medium was changed daily. Expression of GFP was recorded 3 times daily and photographed at 5 DIV using an Olympus CK40 inverted microscope with an FITC filter. This camera has a 'Relief Phase Contrast' which is a new advance in Phase Contrast technique, and can offer a clear observation of thick specimen that is important for retinal organ culture or retinal whole mount photographing.
Subretinal and intravitreal injections
C57BL/6 mice at P7 were injected subretinally or intravitreally with 0.5 ll of AAV1, AAV2 or AAV5 vector in one eye utilizing a previous described method (Pang et al., 2006b) . Briefly, the eyelid was opened by separation with blunt forceps. The eye was slightly prolapsed by modest periocular pressure. The eyelids functioned to hold the globe prolapsed during the procedure. The conjunctiva was cut with the sharp edge of a 30-gauge needle to expose the underlying sclera. The conjunctiva adjacent to the cornea was grasped and rotated with forceps to allow optimal exposure and an aperture was made through the peripheral sclera with the tip of a 30-gauge disposable needle. Once the entry port was made, the tip of a 33-gauge blunt needle mounted on a 10 ll Hamilton Micro Syringe was inserted into the subretinal space or into the vitreous cavity to release the vector. One drop of 1% Atropine eye drop and a small amount of Neomycin & Polymyxin B Sulfates & Dexamethasone Ophthalmic Ointment were applied to the eye following injection and then applied once daily for 3 days. The mice were sacrificed and the globes removed 5 weeks later to prepare either retinal whole mounts for photographing or eyecups for frozen section.
Histology
Retinal explants were fixed overnight in 4% paraformaldehyde in PBS, rinsed four times in PBS, transferred to 30% sucrose in PBS for 5 h, and frozen in optimal-cutting temperature medium (Fisher Scientific, Pittsburph, Pa). Mouse eyes were enucleated and placed in 4% paraformaldehyde in PBS overnight and embedded as described above. 12 lm-thick sections were obtained with a cryostat. GFP-specific fluorescence was analyzed by an Olympus CK40 inverted microscope. True GFP expression was distinguished from background auto fluorescence by comparing the expression patterns through a FITC and a rhodamine filters. Sections expressing GFP were covered with VectaShield Mounting Medium (Vector lab, Burlingame, CA) and photographed using a Spot RT (real-time) digital camera (Diagnostic Instruments Color Digital Cameras, McHenry, IL).
Results
In vitro vs. in vivo: comparison of vector administration to the RGC surface versus intravitreal injection
Analysis of retina whole-mounts of AAV1 vector applied in vitro to the RGC surface of retinal explants showed minimal GFP expression that was present only around the retinal edges and along the four transverse cuts made to flatten the retina, as well as around the optic nerve excision (Fig. 1a) . Histological examination of transverse retinal sections showed scattered GFP expression in Muller cells and RGCs (Fig. 1b) . Whole-mount analysis of AAV1 vector injected intravitreally in vivo showed little transduction in the retina (Fig. 1c) . Histological examination of transverse retinal sections showed GFP expression that was present only focally around the injection site. Transduced cell types included primarily Muller cells and RPE cells in this region (Fig. 1d) .
Whole-mount analysis of AAV2 addition to the RGC surface of in vitro retinal explants yielded robust transgene GFP expression throughout the retina (Fig. 2a) . Histological examination of retinal sections showed the expression mainly resided in Muller cells, RGCs and some in PR cells (Fig. 2b) . Whole-mount analysis at 5 weeks following in vivo intravitreal injection of AAV2 vector showed that most of the retina could be transduced (Fig. 2c) . Retinal sections showed GFP expression predominantly in Muller cells and RGCs (Fig. 2d) .
Whole-mount analysis of AAV5 vector applied to the RGC surface of retinal explants showed GFP expression across the retina (Fig. 3a) . Retinal sections showed that most of the transduced cells were PR cells, RGCs and Muller cells (Fig. 3b) . Whole-mount analysis of intravitreally in vivo injected AAV5 showed minimal transduction in the retina (Fig. 3c) . Histological examination showed that GFP expression was limited to the area around the injection site where scattered PR cells, RPE cells and Muller cells were transduced (Fig. 3d) .
In vitro vs. in vivo: comparison of vector administration to the PR surface versus subretinal injection
Similar to applying AAV1 vector to the RGC surface, addition of AAV1 to the PR surface of the retinal explants showed GFP expression only around the retinal edges and the dissection edges (Fig. 4a) . Transverse sections showed scattered GFP positive cells in these regions, primarily PR and Muller cells (Fig. 4b) . It is important to note that the RPE cell layer was absent from retinal explant cultures so that transduction behavior in the RPE could not be compared. GFP expression could not be detected from whole-mount retinas subretinally injected in vivo with AAV1 vector (Fig. 4c) , however, extensive RPE cell transduction was observed from transverse sections from the eyes following subretinal injection (Fig. 4d) .
Whole-mount analysis of AAV2 vector added to the PR surface of retinal explants showed GFP expression throughout the retina with enhancement near the edges and central areas of the explants (Fig. 5a) . Sections from these explants showed that primarily PR cells were transduced, with some RGCs and Muller cells also transduced but at a lower frequency (Fig. 5b) . Whole-mount from eyes subretinally injected in vivo with AAV2 showed strong GFP expression in about 20% of the retina (Fig. 5c ). Retinal sections through transduced area demonstrated that both RPE and PR cells supported GFP expression with RPE cells highly positive than PR cells (Fig. 5d) .
Whole-mounts of AAV5 applied to the PR surface of the retinal explants in vitro showed GFP expression throughout the retina, with enhancement at the edges, cut areas and central areas of the explant (Fig. 6a) . Sections of these explants showed that PR cells were primarily transduced, with some Muller cells and RGCs also GFPpositive (Fig. 6b) . Retinal whole mounts subretinally injected in vivo with AAV5 also showed strong GFP expression in about 30% of the retina (Fig. 6c) . Both RPE and PR cells were transduced efficiently. By examination of transverse sections, AAV5 mediated qualitatively higher levels of GFP in PR cells than AAV2 when also injected subretinally (Fig. 6d ).
There were no differences between animals in each group (minimum 6) in this study.
A summary of these patterns of transduction and cell specificity for AAV1, 2 and 5 is shown in Fig. 7 , and compares the in vitro organ culture analysis to analysis after conventional in vivo vector injection.
Discussion
The purpose of this study was to develop a simple in vitro retinal organ culture system that would mimic expression of different AAV vector serotypes when injected either subretinally or intravitreally into the neonatal mouse eyes. P7 mice were used in these experiments for both injection and for retinal organ culture. This age was chosen because retinal morphology was better maintained in explants of this age compared to younger or older explants (Pang et al., 2004) .
Qualitatively, transgene GFP expression in retinal organ culture was observed within 24 h following treatment with all three serotypes of AAV although it appeared somewhat quicker with AAV2 and 5 vectors. When vectors were applied to the RGC surface of retinal explants, AAV5-mediated expression appeared weaker than AAV2 because GFP expression was visually detectible 6-8 h earlier with AAV2 than with AAV5 (data not shown). Since expression reached its peak at around 5 DIV in all groups, we decide to evaluate the results at this time although our unpublished data show that GFP expression remained stable for at least 2-3 additional weeks either with vector applied to the PR or RGC surface of the explants. Although these in vitro retinal explants were capable of surviving as long as 4 weeks in vitro, extended culturing time leads to thinning of the retina and poor morphology (Pang et al., 2004) , another reason for choosing 5 DIV to evaluate the results; in contrast, it was 1-2 weeks after injection before in vivo transgene GFP expression was first detected in either RPE, PR, Muller cells or RGC cells. The levels of in vivo GFP expression peaked for all serotypes by 5 weeks post-subretinal or post-intravitreal injection and remained stable for at least 7 months in mice (data not shown).
To ensure that our organ culture assay was a valid surrogate for in vivo injections, we compared the transduction properties of AAV1, AAV2 and AAV5 vectors because to date they have been the most extensively characterized in mice.
The GFP expression from the eyecup in Figs. 1d and 3d is very weak and limited to the injection site, and can only be detected at high magnification. The retinal whole mounts in Fig. 1c or Fig. 3c have no RPE cells and it is difficult to record this weak GFP expression, even near the injection site, when attempting to image the whole retina at low magnification. It is difficult to avoid the random retinal damage during separation of the retina from an eyecup. Hence GFP expression is observed not only along the retinal cut, edge and optic nerve areas but also in these damaged areas, and this may be the reason for the patchy GFP signal in some cultured retinas. The most effective in vivo transduction occurred by intravitreal injection of AAV2 vector that can transfect most cells of the inner retina and by subretinal injection of AAV5 that can transfect most PR and RPE cells. In the retinal organ culture system, following addition of vectors on the RGC surface, AAV2 remained the most effective, transducing mainly RGCs and Muller cells. This is consistent with our intravitreal injection results in neonates that lead to more Muller cell transduction than in adult mice (Liang et al., 2003) . AAV5 vector was the most effective at transducing PR cells both in vivo and in vitro. Unlike in vivo results, AAV5 or AAV2 also supported expression in PR cells when applied to RGC surface of retinal organ cultures. However, in this case because the vector is free to disperse across the full retina in culture, it is likely to have reached the PR surface around the edges (and cuts) of the retinal explant. Thus we attribute PR transduction by AAV5 orAAV2 administered to the RGC side of cultured retinas to vector leakage around the retinal edge, not vector penetration through the retina. We could not test the in vitro ability of AAV5 or AAV1 vector to transduce the RPE because the RPE layer needed to be removed to avoid outer nuclear layer rosette formation during culturing (Pang et al., 2004) .
In summary, we demonstrate here that the in vitro retinal organ culture method is an effective surrogate for in vivo screening of AAV vector behavior in the mouse retina in that it shortens analysis time from 5 weeks to less than one week. This in vitro culture should provide a fast and easy way to estimate the behavior of novel AAV vectors.
